0.5g SRT2104

DRUG2 trials

Sponsors

GlaxoSmithKline, Sirtris, a GSK Company

Conditions

Diabetes Mellitus, Type 2Pulmonary Disease, Chronic Obstructive

Phase 1

Clinical Study to Assess the Effects of SRT2104 and Prednisolone on Biomarkers in Blood in Healthy Volunteers

CompletedNCT00920660

GlaxoSmithKlinePulmonary Disease, Chronic Obstructive

Start: 2009-04-06End: 2009-06-12Updated: 2017-07-07

A Clinical Study to Assess the Effect of Food and Gender on the Pharmacokinetics of SRT2104 Administered as an Oral Suspension or Capsule Formulation to Normal Healthy Volunteers

CompletedNCT00938275

Sirtris, a GSK CompanyDiabetes Mellitus, Type 2

Start: 2009-01-20End: 2009-03-27Updated: 2017-07-21